TrialBritish journal of cancer2008

Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.

A Awada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.